National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 16153 [2010-7088]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Immunotherapy Trials Network.
Date: June 7, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Kenneth L. Bielat, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892–8329, 301–496–7576,
bielatk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
BILLING CODE 4140–01–P
Proposed Substances To Be Evaluated
for Set 24 Toxicological Profiles
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jlentini on DSKJ8SOYB1PROD with NOTICES
[FR Doc. 2010–7088 Filed 3–30–10; 8:45 am]
[ATSDR–259]
BILLING CODE 4140–01–P
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
Jkt 220001
Dated: March 24, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Agency for Toxic Substances and
Disease Registry
[FR Doc. 2010–7178 Filed 3–30–10; 8:45 am]
19:40 Mar 30, 2010
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: June 13–14, 2010.
Time: 7 a.m. to 6 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Diplomat/Ambassador Room,
Bethesda, MD 20814.
Contact Person: Alan P. Koretsky, PhD,
Scientific Director, Division of Intramural
Research, National Institute of Neurological
Disorders & Stroke, NIH, 35 Convent Drive,
Room 6A 908, Bethesda, MD 20892. 301–
435–2232. koretskya@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 24, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
VerDate Nov<24>2008
of Scientific Counselors, National
Institute of Neurological Disorders and
Stroke. The meeting will be closed to
the public as indicated below in
accordance with the provisions set forth
in section 552b(c)(6), Title 5 U.S.C., as
amended for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Neurological
Disorders and Stroke, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
AGENCY: Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Request for comments on the
proposed substances to be evaluated for
Set 24 toxicological profiles.
SUMMARY: This notice announces the list
of proposed substances that will be
evaluated for Comprehensive
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
16153
Environmental Response,
Compensation, and Liability Act of 1980
(CERCLA) Set 24 toxicological profile
development. ATSDR’s Division of
Toxicology and Environmental
Medicine is soliciting public comments
on the list of proposed substances to be
evaluated for toxicological profile
development. ATSDR also will consider
the nomination of any additional,
substances, not on this list, that may
have public health implications.
DATES: Nominations must be submitted
within 30 days of the publication of this
notice.
ADDRESSES: Nominations may be
submitted electronically. Refer to the
section Submission of Nominations
(following) for the specific address.
FOR FURTHER INFORMATION CONTACT: For
further information, contact:
Commander Jessilynn B. Taylor,
Division of Toxicology and
Environmental Medicine, Agency for
Toxic Substances and Disease Registry,
1600 Clifton Road, F–62, Atlanta, GA,
30333; telephone: (770) 488–3313; or email: jbtaylor@cdc.gov.
The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) [42
U.S.C. 9601 et seq.] amended the
CERCLA (or Superfund) [42 U.S.C. 9601
et seq.] by establishing certain
requirements for ATSDR and the U.S.
Environmental Protection Agency (EPA)
with regard to hazardous substances
most commonly found at facilities on
the CERCLA NPL. Among these
statutory requirements is a mandate for
the Administrator of ATSDR to prepare
toxicological profiles for each substance
included on the Priority List of
Hazardous Substances. This identifies
275 hazardous substances that ATSDR
and EPA have determined pose the most
significant potential threat to human
health (https://www.atsdr.cdc.gov/cercla/
07list.html). The availability of the
revised list of the 275 priority
substances was announced in the
Federal Register on March 6, 2008 (73
FR 12178). For prior versions of the list
of substances, see Federal Register
notices dated April 17, 1987 (52 FR
12866); October 20, 1988 (53 FR 41280);
October 26, 1989 (54 FR 43619); October
17, 1990 (55 FR 42067); October 17,
1991 (56 FR 52166); October 28, 1992
(57 FR 48801); February 28, 1994 (59 FR
9486); April 29, 1996 (61 FR 18744;
November 17, 1997 (62 FR 61332);
October 21, 1999 (64 FR 56792); October
25, 2001 (66 FR 54014); and November
7, 2003 (68 FR 63098), December 7,
2005 (70 FR 72840).
SUPPLEMENTARY INFORMATION:
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 75, Number 61 (Wednesday, March 31, 2010)]
[Notices]
[Page 16153]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-7088]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, National Institute of Neurological
Disorders and Stroke. The meeting will be closed to the public as
indicated below in accordance with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and
evaluation of individual intramural programs and projects conducted by
the National Institute of Neurological Disorders and Stroke, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: June 13-14, 2010.
Time: 7 a.m. to 6 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814.
Contact Person: Alan P. Koretsky, PhD, Scientific Director,
Division of Intramural Research, National Institute of Neurological
Disorders & Stroke, NIH, 35 Convent Drive, Room 6A 908, Bethesda, MD
20892. 301-435-2232. koretskya@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: March 24, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-7088 Filed 3-30-10; 8:45 am]
BILLING CODE 4140-01-P
